32 GENES FOUND

Show / hide columns »

XML | RDF | TAB | Page of 1

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CACNA1FCalcium channel, voltage-dependent, L type, alpha 1F subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1ICalcium channel, voltage-dependent, T type, alpha 1I subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CATSPER2Cation channel, sperm associated 2Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CNGA3Cyclic nucleotide gated channel alpha 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CNGA4Cyclic nucleotide gated channel alpha 4Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
HCN2Hyperpolarization activated cyclic nucleotide gated potassium channel 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
HCN4Hyperpolarization activated cyclic nucleotide gated potassium channel 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA7Potassium channel, voltage gated shaker related subfamily A, member 7FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNH2Potassium channel, voltage gated eag related subfamily H, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNH4Potassium channel, voltage gated eag related subfamily H, member 4Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH6Potassium channel, voltage gated eag related subfamily H, member 6Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH8Potassium channel, voltage gated eag related subfamily H, member 8Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ10Potassium channel, inwardly rectifying subfamily J, member 10Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNJ13Potassium channel, inwardly rectifying subfamily J, member 13Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ4Potassium channel, inwardly rectifying subfamily J, member 4Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNJ6Potassium channel, inwardly rectifying subfamily J, member 6Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNK12Potassium channel, two pore domain subfamily K, member 12Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK16Potassium channel, two pore domain subfamily K, member 16Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK3Potassium channel, two pore domain subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK4Potassium channel, two pore domain subfamily K, member 4Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK9Potassium channel, two pore domain subfamily K, member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNQ3Potassium channel, voltage gated KQT-like subfamily Q, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNS1Potassium voltage-gated channel, modifier subfamily S, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNV1Potassium channel, voltage gated modifier subfamily V, member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
SCN10ASodium channel, voltage gated, type X alpha subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Not detected
SCN5ASodium channel, voltage gated, type V alpha subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
TRPC4Transient receptor potential cation channel, subfamily C, member 4Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
TRPC5Transient receptor potential cation channel, subfamily C, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM3Transient receptor potential cation channel, subfamily M, member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM6Transient receptor potential cation channel, subfamily M, member 6Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM8Transient receptor potential cation channel, subfamily M, member 8FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
TRPV1Transient receptor potential cation channel, subfamily V, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed

Page of 1